Idiopathic Pulmonary Fibrosis clinical trials at UC Irvine

2 in progress, 0 open to eligible people

Showing trials for

  • Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

    Sorry, in progress, not accepting new patients

    Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.

    Orange 5379513, California 5332921 and other locations

  • TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

    Sorry, in progress, not accepting new patients

    The primary objective of this study is to evaluate the safety and tolerability of oral daily administration of TTI-101 over a 12-week treatment duration in participants with idiopathic pulmonary fibrosis (IPF).

    Orange 5379513, California 5332921 and other locations

Last updated: